Standout Papers

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plu... 1994 2026 2004 2015 4.7k
  1. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial (2001)
    Michael P. Manns, John G. McHutchison et al. The Lancet
  2. Classification of chronic hepatitis: Diagnosis, grading and staging (1994)
    Valeer Desmet, Michael A. Gerber et al. Hepatology
  3. Boceprevir for Untreated Chronic HCV Genotype 1 Infection (2011)
    Fred Poordad, Jonathan McCone et al. New England Journal of Medicine
  4. Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis (2012)
    Rozanne C. de Veer, Bart J. Veldt et al. JAMA
  5. Diagnosis and Management of Autoimmune Hepatitis (2010)
    Michael P. Manns, Albert J. Czaja et al. Hepatology
  6. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C (2002)
    Thierry Poynard, John G. McHutchison et al. Gastroenterology
  7. Adherence to combination therapy enhances sustained response in genotype-1–infected patients with chronic hepatitis C (2002)
    John G. McHutchison, Michael P. Manns et al. Gastroenterology
  8. A New Population of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Induces CD4+CD25+Foxp3+ T Cells (2008)
    Bastian Hoechst, Lars A. Ormandy et al. Gastroenterology
  9. Early Virologic Response to Treatment With Peginterferon Alfa–2B Plus Ribavirin in Patients With Chronic Hepatitis C (2003)
    Gary L. Davis, John B. Wong et al. Hepatology
  10. EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure (2017)
    Julia Wendon, Juan Córdoba et al. Journal of Hepatology
  11. Increased Populations of Regulatory T Cells in Peripheral Blood of Patients with Hepatocellular Carcinoma (2005)
    Lars A. Ormandy, Tina Hillemann et al. Cancer Research
  12. Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor # (2009)
    Bastian Hoechst, Lars A. Ormandy et al. Hepatology
  13. Telaprevir for Previously Treated Chronic HCV Infection (2010)
    John G. McHutchison, Michael P. Manns et al. New England Journal of Medicine
  14. Treating viral hepatitis C: efficacy, side effects, and complications (2006)
    Michael P. Manns et al. Gut
  15. Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases (2019)
    Cara L. Mack, David Adams et al. Hepatology
  16. Hepatitis C virus infection (2017)
    Michael P. Manns, Marı́a Buti et al. Nature Reviews Disease Primers
  17. Autoimmune hepatitis (2018)
    Giorgina Mieli‐Vergani, Diego Vergani et al. Nature Reviews Disease Primers
  18. Breakthroughs in hepatitis C research: from discovery to cure (2022)
    Michael P. Manns, Benjamin Maasoumy Nature Reviews Gastroenterology & Hepatology

Immediate Impact

8 by Nobel laureates 15 from Science/Nature 107 standout
Sub-graph 1 of 17

Citing Papers

CAR immune cells: design principles, resistance and the next generation
2023 StandoutNature
Fibroblasts: Origins, definitions, and functions in health and disease
2021 Standout

Works of Michael P. Manns being referenced

Direct Reprogramming of Hepatic Myofibroblasts into Hepatocytes In Vivo Attenuates Liver Fibrosis
2016
Prevention of Allograft Rejection by Use of Regulatory T Cells With an MHC-Specific Chimeric Antigen Receptor
2016

Author Peers

Author Last Decade Papers Cites
Michael P. Manns 45849 40953 10951 1.3k 75.1k
Peter R. Galle 18671 15648 10714 1.2k 53.9k
David E. Kleiner 17152 31134 7096 510 49.1k
David A. Brenner 21617 26184 8883 507 58.1k
Stefan Zeuzem 33445 32059 3983 1.0k 45.8k
Frank Tacke 15955 21618 6060 695 43.6k
Roger Williams 14337 15086 5468 817 45.0k
Thomas E. Starzl 22074 12570 31877 1.2k 56.0k
M. Eric Gershwin 12795 11626 6938 868 38.4k
Kazuaki Chayama 14718 15457 10433 1.4k 44.3k
Hashem B. El‐Serag 25616 27368 22584 641 67.1k

All Works

Loading papers...

Rankless by CCL
2026